FBInvestor
Stocks / Plus Therapeutics Inc
Institutional Ownership

Plus Therapeutics Inc

CUSIP 72941H509COMPSTVQ1 2026

13D / 13G Filings
8
Schedule 13D/13G on record
Beneficial Filers
5
Distinct reporting persons
Largest Stake
10.0%
Max % of class reported
Institutional Holders
21
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

8 filings · latest Jan 22, 2026

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Jan 22, 2026Cvi Investments, Inc.13G6.9%12.37MSEC
2Aug 14, 2025S.H.N. Financial Investments Ltd.13G/A1.5%1.50MSEC
3Jul 29, 2025Orin Hirschman13G/A3.9%1.28MSEC
4Jun 25, 2025The Hewlett Fund LP13G/ASEC
5May 22, 2025The Hewlett Fund LP13G8.3%2.01MSEC
6Mar 18, 2025S.H.N. Financial Investments Ltd.13G10.0%1.21MSEC
7Feb 10, 2025Orin Hirschman13G/A9.5%5.61TSEC
8Jun 5, 2024Hirschman Orin13G9.9%568.7KSEC

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →
#FundSharesValue
1Geode Capital Management, LLC2.02M$328.0K
2Blackrock, Inc.1.78M$288.8K
3State Street Corp468.9K$76.2K
4Northern Trust Corp293.3K$47.7K
5Millennium Management LLC271.6K$44.2K
6Two Sigma Securities, LLC142.8K$23.2K
7Xtx Topco Ltd116.0K$18.9K
8Citigroup Inc93.0K$15.1K
9Ubs Group AG87.8K$14.3K
10Mercer Global Advisors Inc /Adv64.1K$10.4K